Clinical effect of amiodarone combined with bisoprolol in patients with congestive heart failure and ventricular arrhythmia
10.3969/j.issn.1005-1678.2017.09.122
- VernacularTitle:胺碘酮联合比索洛尔对充血性心力衰竭并室性心律失常患者的疗效
- Author:
Wei YU
;
Derong WANG
- Keywords:
Amiodarone;
pisolol;
congestive heart failure;
ventricular arrhythmia
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(9):275-277
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore clinical effect and safety of amiodarone combined with bisoprolol in patients with congestive heart failure and ventricular arrhythmia. Methods Selected 100 cases with congestive heart failure and ventricular arrhythmia in our hospital from January 2011 to April 2017 as research objectives and divided them into two groups randomly with 50 cases in each group. Provided amiodarone to control group and provided amiodarone combined with bisoprolol to observation group. Compared two groups' arrhythmia and cardiac function, heart rate, ejection fraction, QT time (QTc) corrected for heart rate before and after treatment as well as adverse events. Results Observation group's effective rate of arrhythmia treatment and the effective rate of cardiac function were 94.00％, 96.00％, those were significant higher than control group's 70.00％, 78.00％ (P<0.05). Two groups' heart rate and ejection fraction score after 3 month treatment were significant higher than those before treatment (P<0.05), and observation group's improvement was more significant (P<0.05). Observation group's QTc was significantly prolonged after 3 months of treatment (P<0.05), but control group's QTc did not change significantly. There was no significant difference in the incidence of adverse reactions between the two groups. Results Amiodarone combined with bisoprolol has significant clinical effect on patients with congestive heart failure and ventricular arrhythmia. It is safe and worthy to be promoted clinically.
